Optimizatsiya ranney diagnostiki zabolevaniy predstatel'noy zhelezy v usloviyakh megapolisa


Cite item

Full Text

Abstract

One of the aims in the strategy of Moscow health service is perfection of early diagnosis of urological diseases. Examination of about 1.500000 males over 50 years was conducted in 2002-2007. The number of PSA tests rose 5-fold for 5 years. The number of ultrasonographies and transrectal ultrasonic investigations of the prostate rose from 21650 (2002) to 128890 (2007), the number of polyfocal biopsies - from 2165 (2002) to 12219 (2007). The rate of detection of prostatic diseases increased from 1146 cases per 100000 adult male population (1999) to 2097 (2007). Chronic prostatitis was registered in 17.8%, prostatic adenoma in 29.6% examinees, new cases of prostatic cancer were detected in 0.86% examinees. Standard prostatic cancer morbidity rose from 30.4 to 47.0 per 100000 male population. Percentage of early detected prostatic cancer increased from 42.9% in 2000 to 62% in 2007, detection of prostatic cancer stage III-IV reduced from 27.3% in 2000 to 16.6% in 2007. Thus, new prophylactic measures improved efficacy of outpatient urological service, raised rate of detection of chronic prostatitis, prostatic adenoma, prostatic cancer

References

  1. Шевченко Ю. Л. Врач и Государство, здравоохранение и нравственность, медицина и право. Экономика здравоохран. 1999; 11-12.
  2. Матвеев Б. П., Комарова Л. Е., Карякин О. Б. Урол. и нефрол. 1997; 2: 53-55.
  3. Гориловский Л. М. Заболевания предстательной железы в пожилом возрасте. M.; 1999.
  4. Матвеев Б. П. Эпидемиология рака предстательной железы. В кн.: Клиническая онкоурология. М.; 2003. 435-440.
  5. Сивков А. В., Аполихин О. И. Рак предстательной железы. В кн.: Материалы X Российского съезда урологов. М.; 2002. 351-371.
  6. Chu K. C., Tarone R. E., Freeman H. P. Trends in prostate cancer mortality among black men and white men in the United States. Cancer 2003; 97: 1507-1516.
  7. Oliver S. E., Gunnell D., Donovan J. L. Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet 2000; 355: 1788-1789.
  8. Oliver S. E., May M. T., Gunnell D. International trends in prostate-cancer mortality in the "PSA ERA". Int. J. Cancer 2001; 92: 893-898.
  9. Stephenson R. A., Smart C. R., Mineau G. P. et al. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence-data from the Utah Cancer Registry. Cancer 1996; 77: 1342-1348.
  10. Лоран О. Б., Сегал А. С. Хронический простатит. В кн.: Материалы X Российского съезда урологов. М.; 2002. 209- 222.
  11. Максимов В. А., Карпов В. К., Кайсаров Д. Е. Заболеваемость раком предстательной железы и проблемы скрининга в г. Москве. В кн.: Материалы Всероссийской науч.-практ. конф. "Современные возможности и новые направления в диагностике рака почки, мочевого пузыря, предстательной железы". Уфа 25-27 июня 2001 года. Уфа; 2001. 70-71.
  12. Hoeksema M. J., Law С. Cancer mortality rates fall: a turning point for the nation. J. Natl. Cancer Inst. 1996; 88: 1706-1707.
  13. Schroder F. H. Screening for prostate cancer. Urol. Clin. N. Am. 2003; 30: 239-251.
  14. Crawford E. D., D'Amico V. D., Djavan B. et al. In: 15th International prostate cancer update. 2005, February 9-13. Vail, Colorado; 2005.
  15. Hsing A. W., Tsao L., Devesa S. S. International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer 2000; 85: 60-67.
  16. Hankey B. F., Feuer E. J., Clegg L. X. et al. Cancer surveillance series: interpreting trends in prostate cancer. Part I: Evidence of the effects of screening in resent incidence, mortality and survival rates. J. Natl. Cancer Inst. 1999; 91: 1017-1021.
  17. Hardy D. O., Scher H. I., Bogenreider Т. et al. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of on set. J. Clin. Endocrinol. 1996; 81: 4400-4405.
  18. Ross R. K., Henderson B. E. Do diet and androgen after prostate cancer risk via a common etiologic pathway? J. Natl. Cancer Inst. 1994; 86: 252-254.
  19. Портнов А. С. Хирургическое лечение аденомы и рака предстательной железы. М.: Медицина; 1989. 107.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies